The Food and Drugs Authority has provided technical support to the Netherlands Pharmacovigilance Centre (LAREB) to provide Qualified Persons for Pharmacovigilance (QPPV) training.
The training is for regulators from the National Medicine Regulatory Authorities (NMRAs) of four African countries namely; Ethiopian Food and Drugs Authority, Pharmacy and Poisons Board (Kenya), Rwanda Food and Drugs Authority, and Tanzania Medicines and Medical Devices Authority under the PROFORMA Project
The six-day virtual training under the theme "Teach the Teacher for QPPV" had the goal to equip the regulators with the knowledge to be able to develop country-specific QPPV training and implementation plans tailored to address country-related pharmacovigilance challenges.
The training was attended by over 45 participants with staff from the NMRAs as well as participants from some Medical Universities such as Addis Ababa University (Ethiopia), Muhimbili University of Health and Allied Sciences (Tanzania), University of Nairobi (Kenya), and the University of Rwanda.
FDA facilitated a session on the underlisted:
- Roles and responsibilities of QPPVs,
- Purpose and evaluation of regulatory documents including Periodic Safety Update of Reports (PSUR/PBRER) and Risk Management Plans (RMPs)
- Principles of benefits and risks evaluation in the review of these documents.
- Pharmacovigilance inspections and audits
In addition to the formal presentations, the FDA was able to share its experience in the implementation of legal pharmacovigilance requirements for marketing authorization holders.
The FDA implemented the QPPV concept in 2015 and has since trained 172 QPPV and conducted over 71 Good Pharmacovigilance Practice Inspection.
The FDA is a Regional Centre of Regulatory Excellence (RCORE) for pharmacovigilance and in 2021, the FDA’s vigilance function was assessed as Maturity level 4 based on the WHO Global Benchmarking Tool.
This is the highest level of the ranking system.
The FDA looks forward to continuously contributing to the development and strengthening of pharmacovigilance activities in Africa and globally to ensure patient safety.
Latest Stories
-
Baby abandoned in manhole in Tema Community 1
7 mins -
We’ll establish fiscal council to rein in excessive borrowing – Finance Minister
13 mins -
Mortuary workers issue fresh strike threat
17 mins -
‘Lapses in banking system are not unique’ – John Awuah on managing fraud in Ghana’s Banks
25 mins -
Bawumia confident of victory in 2024 election
59 mins -
Strengthening audit institutions essential for tackling fiscal mismanagement – Domelevo
1 hour -
Healthy Aging: The Role of the Gut Microbiome and How Diet Can Help
1 hour -
Seek medical care, diagnosis for breast cancer – Dr Abiti to women
1 hour -
Hardship: Men now collect marriage list from different families to get cheapest – Report
1 hour -
‘If you’re looking for trouble, you’ll get it,’ Falz tells VeryDarkMan
1 hour -
Paramount Chief of Avenor grateful to NPP, calls for completion of Agenda 111 project
2 hours -
Bawumia commissions ultramodern office complex for Ho Municipal Assembly
2 hours -
Bawumia declares NPP’s infrastructure record unmatched
2 hours -
Importers face duty on Electric Vehicles despite gov’t’s exemption promises
2 hours -
4 additional Democracy Hub protesters discharged
2 hours